Application of liquid biopsies to identify genomic factors associated with therapy resistance in castration resistant prostate cancer

Daniel J. Crona, Young E. Whang

Abstract

For over 70 years, androgen deprivation therapy (ADT) has been a fundamental treatment paradigm for advanced prostate cancer.